How many insider trades does FilingIQ track for BCLI?

FilingIQ tracks 154 Form 4 insider transactions for BCLI (BRAINSTORM CELL THERAPEUTICS INC.), covering filings from Aug 17, 2015 onwards. 6 of those were filed in the last 90 days.

Are BCLI insiders net buyers or net sellers?

Across the full Form 4 history for BCLI, 26 transactions (17%) were open-market purchases and 15 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BCLI insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BCLI in?

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $7.94M.

BCLI insider trading

OTC Markets OTCQB Healthcare

BRAINSTORM CELL THERAPEUTICS INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

154

Last 90 days

Buys / sells

17% / 10%

Market cap

$7.94M

About BRAINSTORM CELL THERAPEUTICS INC.

Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is involved in the development of NurOwn, which has completed Phase IIIb clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for treatment of other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Company website: www.brainstorm-cell.com

BCLI insider activity at a glance

FilingIQ has scored 154 insider transactions for BCLI since Aug 17, 2015. The most recent filing in our index is dated Feb 26, 2026.

Across the full history, 26 open-market purchases and 15 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BCLI insider trades is 51.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BCLI trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,147

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 185

Adaptive Biotechnologies Corp

GH 173

Guardant Health, Inc.

ISRG 169

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for BCLI?: FilingIQ tracks 154 Form 4 insider transactions for BCLI (BRAINSTORM CELL THERAPEUTICS INC.), covering filings from Aug 17, 2015 onwards. 6 of those were filed in the last 90 days.
Are BCLI insiders net buyers or net sellers?: Across the full Form 4 history for BCLI, 26 transactions (17%) were open-market purchases and 15 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BCLI insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BCLI in?: BRAINSTORM CELL THERAPEUTICS INC. (BCLI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $7.94M.

Methodology & sources

Every BCLI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.